{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:39:25Z","timestamp":1790260765528,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2021,5,13]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Peritoneal metastasis is a common form of metastasis among advanced gastric cancer patients. In this study, we reported the identification of LIM domain kinase 1 (LIMK1) as a promoter of gastric cancer peritoneal metastasis, and its potential to be a therapeutic target of dabrafenib (DAB). Using transcriptomic sequencing of paired gastric cancer peritoneal metastasis, primary tumors, and normal gastric tissues, we first unveiled that LIMK1 is selectively up-regulated in metastatic tumors. Increased LIMK1 in gastric cancer peritoneal metastasis was validated by immunohistochemistry analysis of an independent patient cohort. In vitro functional studies demonstrated that LIMK1 knockout or knockdown significantly inhibited cell migration and invasion of gastric cancer cells. LIMK1 knockout also abrogated peritoneal and liver metastases of gastric cancer cells in nude mice in vivo. Dabrafenib, a small molecule targeting LIMK1, was found to decrease cell migration and invasion of gastric cancer cells in vitro and abolish peritoneal and liver metastasis formation in vivo. Mechanistically, either LIMK1 knockout or Dabrafenib inhibited LIMK1 expression and phosphorylation of its downstream target cofilin. Taken together, our results demonstrated that LIMK1 functions as a metastasis promoter in gastric cancer by inhibiting LIMK1-p-cofilin and that Dabrafenib has the potential to serve as a novel treatment for gastric cancer peritoneal metastasis.<\/jats:p>","DOI":"10.1038\/s41388-021-01656-1","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T09:11:42Z","timestamp":1618996302000},"page":"3422-3433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target"],"prefix":"10.1038","volume":"40","author":[{"given":"Xi","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1362-3541","authenticated-orcid":false,"given":"Chi Chun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4651-677X","authenticated-orcid":false,"given":"Wei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-3707","authenticated-orcid":false,"given":"Ka Fai","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-112X","authenticated-orcid":false,"given":"Philip Wai Yan","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8743-325X","authenticated-orcid":false,"given":"Guiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5008-2153","authenticated-orcid":false,"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7219-5810","authenticated-orcid":false,"given":"Enders Kwok Wai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"1656_CR1","first-page":"26","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14:26\u201338.","journal-title":"Prz Gastroenterol."},{"key":"1656_CR2","doi-asserted-by":"publisher","first-page":"38501","DOI":"10.18632\/oncotarget.16258","volume":"8","author":"F Pirini","year":"2017","unstructured":"Pirini F, Noazin S, Jahuira-Arias MH, Rodriguez-Torres S, Friess L, Michailidi C, et al. Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies. Oncotarget. 2017;8:38501\u201316.","journal-title":"Oncotarget"},{"key":"1656_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, Van Gestel YR, Van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622\u20138.","journal-title":"Int J Cancer"},{"key":"1656_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ssu.10042","volume":"21","author":"PH Sugarbaker","year":"2003","unstructured":"Sugarbaker PH, Yu W, Yonemura Y. Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol. 2003;21:233\u201348.","journal-title":"Semin Surg Oncol"},{"key":"1656_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000096002","volume":"52","author":"S Ishizone","year":"2006","unstructured":"Ishizone S, Maruta F, Saito H, Koide N, Sugiyama A, Nakayama J, et al. Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer. Chemotherapy. 2006;52:301\u20137.","journal-title":"Chemotherapy"},{"key":"1656_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/1566524017666170807144946","volume":"17","author":"R Bell","year":"2017","unstructured":"Bell R, Barraclough R, Vasieva O. Gene expression meta-analysis of potential metastatic breast cancer markers. Curr Mol Med. 2017;17:200\u201310.","journal-title":"Curr Mol Med"},{"key":"1656_CR7","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1158\/0008-5472.CAN-16-2717","volume":"77","author":"JM Cejalvo","year":"2017","unstructured":"Cejalvo JM, De Due\u00f1as EM, Galv\u00e1n P, Garc\u00eda-Recio S, Gasi\u00f3n OB, Par\u00e9 L, et al. Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer. Cancer Res. 2017;77:2213\u201321.","journal-title":"Cancer Res"},{"key":"1656_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883\u201392.","journal-title":"N Engl J Med"},{"key":"1656_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ng1060","volume":"33","author":"S Ramaswamy","year":"2003","unstructured":"Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003;33:49\u201354.","journal-title":"Nat Genet"},{"key":"1656_CR10","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.humpath.2013.11.003","volume":"45","author":"B Davidson","year":"2014","unstructured":"Davidson B, Abeler VM, F\u00f8rsund M, Holth A, Yang Y, Kobayashi Y, et al. Gene expression signatures of primary and metastatic uterine leiomyosarcoma. Hum Pathol. 2014;45:691\u2013700.","journal-title":"Hum Pathol"},{"key":"1656_CR11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.biocel.2006.11.011","volume":"39","author":"O Bernard","year":"2007","unstructured":"Bernard O. Lim kinases, regulators of actin dynamics. Int J Biochem Cell Biol. 2007;39:1071\u20136.","journal-title":"Int J Biochem Cell Biol"},{"key":"1656_CR12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1126\/science.285.5429.895","volume":"285","author":"M Maekawa","year":"1999","unstructured":"Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science (80-). 1999;285:895\u20138.","journal-title":"Science (80-)"},{"key":"1656_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejca.2007.10.017","volume":"44","author":"A Pierce","year":"2008","unstructured":"Pierce A, Barron N, Linehan R, Ryan E, O\u2019Driscoll L, Daly C, et al. Identification of a novel, functional role for S100A13 in invasive lung cancer cell lines. Eur J Cancer. 2008;44:151\u20139.","journal-title":"Eur J Cancer"},{"key":"1656_CR14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tranon.2018.06.003","volume":"11","author":"Y Gu","year":"2018","unstructured":"Gu Y, Chow MJ, Kapoor A, Mei W, Jiang Y, Yan J, et al. Biphasic alteration of butyrylcholinesterase (BChE) during prostate cancer development. Transl Oncol. 2018;11:1012\u201322.","journal-title":"Transl Oncol"},{"key":"1656_CR15","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/leu.2016.88","volume":"30","author":"BoM Dal","year":"2016","unstructured":"Dal BoM, Bulian P, Bomben R, Zucchetto A, Rossi FM, Pozzo F, et al. CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia. Leukemia. 2016;30:2011\u20138.","journal-title":"Leukemia"},{"key":"1656_CR16","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.3892\/or.2014.3461","volume":"32","author":"P Chen","year":"2014","unstructured":"Chen P, Zeng M, Zhao Y, Fang X. Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1\/cofilin signaling. Oncol Rep. 2014;32:2070\u20136.","journal-title":"Oncol Rep."},{"key":"1656_CR17","unstructured":"GlaxoSmithKline. Tafinlar (dabrafenib capsules): US prescribing information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/202806s001lbl.pdf. 2013."},{"key":"1656_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep45624","volume":"7","author":"J Su","year":"2017","unstructured":"Su J, Zhou Y, Pan Z, Shi L, Yang J, Liao A, et al. Downregulation of LIMK1-ADF\/cofilin by DADS inhibits the migration and invasion of colon cancer. Sci Rep. 2017;7:45624.","journal-title":"Sci Rep."},{"key":"1656_CR19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3892\/or.2012.2168","volume":"29","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Su J, Shi L, Liao Q, Su Q. DADS downregulates the Rac1-ROCK1\/PAK1-LIMK1-ADF\/cofilin signaling pathway, inhibiting cell migration and invasion. Oncol Rep. 2013;29:605\u201312.","journal-title":"Oncol Rep."},{"key":"1656_CR20","doi-asserted-by":"publisher","unstructured":"Ling H, Ji X, Lei Y, Jia Y, Liu F, Xia H et al. Diallyl disulfide induces downregulation and inactivation of cofilin 1 differentiation via the Rac1\/ROCK1\/LIMK1 pathway in leukemia cells. Int J Oncol. 2020. https:\/\/doi.org\/10.3892\/ijo.2020.4968.","DOI":"10.3892\/ijo.2020.4968"},{"key":"1656_CR21","first-page":"1","volume":"17","author":"Z Wang","year":"2019","unstructured":"Wang Z, Chen JQ, Liu JL, Tian L. Issues on peritoneal metastasis of gastric cancer: an update. World. J Surg Oncol. 2019;17:1\u20138.","journal-title":"J Surg Oncol."},{"key":"1656_CR22","doi-asserted-by":"publisher","unstructured":"Sun F, Feng M, Guan W Mechanisms of peritoneal dissemination in gastric cancer. Oncol. Lett. 2017. https:\/\/doi.org\/10.3892\/ol.2017.7149.","DOI":"10.3892\/ol.2017.7149"},{"key":"1656_CR23","doi-asserted-by":"publisher","unstructured":"Paget S THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. Lancet. 1889. https:\/\/doi.org\/10.1016\/S0140-6736(00)49915-0.","DOI":"10.1016\/S0140-6736(00)49915-0"},{"key":"1656_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-75","volume":"10","author":"BV McConnell","year":"2011","unstructured":"McConnell BV, Koto K, Gutierrez-Hartmann A. Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression. Mol Cancer. 2011;10:75.","journal-title":"Mol Cancer"},{"key":"1656_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.phymed.2018.06.009","volume":"49","author":"J Fu","year":"2018","unstructured":"Fu J, Yu J, Chen J, Xu H, Luo Y, Lu H. In vitro inhibitory properties of sesquiterpenes from Chloranthus serratus on cell motility via down-regulation of LIMK1 activation in human breast cancer. Phytomedicine. 2018;49:23\u201331.","journal-title":"Phytomedicine"},{"key":"1656_CR26","doi-asserted-by":"publisher","unstructured":"Hohmann, Dehghani. The Cytoskeleton\u2014A Complex Interacting Meshwork. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8040362.","DOI":"10.3390\/cells8040362"},{"key":"1656_CR27","doi-asserted-by":"publisher","unstructured":"Fife CM, McCarroll JA, Kavallaris M Movers and shakers: Cell cytoskeleton in cancer metastasis. Br. J. Pharmacol. 2014. https:\/\/doi.org\/10.1111\/bph.12704.","DOI":"10.1111\/bph.12704"},{"key":"1656_CR28","doi-asserted-by":"publisher","unstructured":"Tang Y, He Y, Zhang P, Wang J, Fan C, Yang L et al. LncRNAs regulate the cytoskeleton and related Rho\/ROCK signaling in cancer metastasis. Mol Cancer. 2018. https:\/\/doi.org\/10.1186\/s12943-018-0825-x.","DOI":"10.1186\/s12943-018-0825-x"},{"key":"1656_CR29","doi-asserted-by":"publisher","unstructured":"Lee SY, Kim W, Lee YG, Kang HJ, Lee SH, Park SY et al. Identification of sennoside A as a novel inhibitor of the slingshot (SSH) family proteins related to cancer metastasis. Pharmacol Res. 2017. https:\/\/doi.org\/10.1016\/j.phrs.2017.03.003.","DOI":"10.1016\/j.phrs.2017.03.003"},{"key":"1656_CR30","doi-asserted-by":"publisher","unstructured":"Puszkiel A, No\u00e9 G, Bellesoeur A, Kramkimel N, Paludetto MN, Thomas-Schoemann A et al. Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib. Clin. Pharmacokinet. 2019. https:\/\/doi.org\/10.1007\/s40262-018-0703-0.","DOI":"10.1007\/s40262-018-0703-0"},{"key":"1656_CR31","unstructured":"Jinhua Wang NG Dabrafenib KINOMEscan. 2015.https:\/\/lincs.hms.harvard.edu\/db\/datasets\/20131\/main."},{"key":"1656_CR32","first-page":"772","volume":"56","author":"H Ling","year":"2020","unstructured":"Ling H, Ji X, Lei Y, Jia Y, Liu F, Xia H, et al. Diallyl disulfide induces downregulation and inactivation of cofilin 1 differentiation via the Rac1\/ROCK1\/LIMK1 pathway in leukemia cells. Int J Oncol. 2020;56:772\u201382.","journal-title":"Int J Oncol"},{"key":"1656_CR33","doi-asserted-by":"publisher","unstructured":"Yu Q, Gratzke C, Wang Y, Herlemann A, Sterr CM, Rutz B et al. Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3. Br J Pharmacol. 2018. https:\/\/doi.org\/10.1111\/bph.14201.","DOI":"10.1111\/bph.14201"},{"key":"1656_CR34","doi-asserted-by":"publisher","unstructured":"Rak R, Haklai R, Elad-Tzfadia G, Wolfson HJ, Carmeli S, Kloog Y Novel LIMK2 inhibitor blocks Panc-1 tumor growth in a mouse xenograft model. Oncoscience. 2014. https:\/\/doi.org\/10.18632\/oncoscience.7.","DOI":"10.18632\/oncoscience.7"},{"key":"1656_CR35","doi-asserted-by":"publisher","unstructured":"Henderson BW, Greathouse KM, Ramdas R, Walker CK, Rao TC, Bach SV et al. Pharmacologic inhibition of LIMK1 provides dendritic spine resilience against \u03b2-amyloid. Sci Signal. 2019. https:\/\/doi.org\/10.1126\/scisignal.aaw9318.","DOI":"10.1126\/scisignal.aaw9318"},{"key":"1656_CR36","doi-asserted-by":"publisher","unstructured":"Mashiach-Farkash E, Rak R, Elad-Sfadia G, Haklai R, Carmeli S, Kloog Y et al. Computer-Based identification of a novel LIMK1\/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton. Oncotarget 2012. https:\/\/doi.org\/10.18632\/oncotarget.525.","DOI":"10.18632\/oncotarget.525"},{"key":"1656_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10120-016-0662-9","volume":"20","author":"D Kobayashi","year":"2017","unstructured":"Kobayashi D, Kodera Y. Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Gastric Cancer. 2017;20:111\u201321.","journal-title":"Gastric Cancer"},{"key":"1656_CR38","doi-asserted-by":"publisher","unstructured":"Seshadri RA, Glehen O Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World J. Gastroenterol. 2016. https:\/\/doi.org\/10.3748\/wjg.v22.i3.1114.","DOI":"10.3748\/wjg.v22.i3.1114"},{"key":"1656_CR39","unstructured":"Dedrick RL, Myers CE, Bungay PM, Devita VT Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep. 1978."},{"key":"1656_CR40","doi-asserted-by":"publisher","unstructured":"Chan DYS, Syn NLX, Yap R, Phua JNS, Soh TIP, Chee CE et al. Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready? J Gastrointest Surg. 2017. https:\/\/doi.org\/10.1007\/s11605-016-3336-3.","DOI":"10.1007\/s11605-016-3336-3"},{"key":"1656_CR41","doi-asserted-by":"publisher","unstructured":"Hsieh SHK, Ferraro GB, Fournier AE Myelin-associated inhibitors regulate cofilin phosphorylation and neuronal inhibition through LIM kinase and slingshot phosphatase. J Neurosci. 2006. https:\/\/doi.org\/10.1523\/JNEUROSCI.2806-05.2006.","DOI":"10.1523\/JNEUROSCI.2806-05.2006"},{"key":"1656_CR42","doi-asserted-by":"publisher","unstructured":"Tursun B, Schl\u00fcter A, Peters MA, Viehweger B, Ostendorff HP, Soosairajah J et al. The ubiquitin ligase Rnf6 regulates local LIM kinase 1 levels in axonal growth cones. Genes Dev. 2005. https:\/\/doi.org\/10.1101\/gad.1340605.","DOI":"10.1101\/gad.1340605"},{"key":"1656_CR43","doi-asserted-by":"publisher","unstructured":"Coolen M, Bally-Cuif L MicroRNAs in brain development and physiology. Curr. Opin. Neurobiol. 2009. https:\/\/doi.org\/10.1016\/j.conb.2009.09.006.","DOI":"10.1016\/j.conb.2009.09.006"},{"key":"1656_CR44","doi-asserted-by":"publisher","unstructured":"Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M et al. A brain-specific microRNA regulates dendritic spine development. Nature. 2006. https:\/\/doi.org\/10.1038\/nature04367.","DOI":"10.1038\/nature04367"},{"key":"1656_CR45","doi-asserted-by":"publisher","unstructured":"Meng Y, Zhang Y, Tregoubov V, Janus C, Cruz L, Jackson M et al. Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron. 2002. https:\/\/doi.org\/10.1016\/S0896-6273(02)00758-4.","DOI":"10.1016\/S0896-6273(02)00758-4"},{"key":"1656_CR46","doi-asserted-by":"publisher","unstructured":"Lim MK, Kawamura T, Ohsawa Y, Ohtsubo M, Asakawa S, Takayanagi A et al. Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination. Exp Cell Res. 2007. https:\/\/doi.org\/10.1016\/j.yexcr.2007.04.016.","DOI":"10.1016\/j.yexcr.2007.04.016"},{"key":"1656_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science (80-). 2014;343:84\u201387.","journal-title":"Science (80-)"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-021-01656-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-021-01656-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-021-01656-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:21:40Z","timestamp":1684617700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-01656-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":47,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2021,5,13]]}},"alternative-id":["1656"],"URL":"https:\/\/doi.org\/10.1038\/s41388-021-01656-1","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"12 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}